Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00244075 · ClinicalTrials.gov registry record · Phase 2
Effects of Nutritional Supplementation on Protein and Energy Homeostasis in Malnourished Chronic Hemodialysis Patients
A Phase 2 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 2
- Development phase
- 46
- Enrollment target
NCT00244075 is a Phase 2 study that has completed, run by Vanderbilt University. The registered enrollment target is 46 participants.
The verdict
NCT00244075, a Phase 2 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 46 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate the metabolic effects of concomitant use of three consecutive doses of recombinant human growth hormone over three days and exercise during continuous nutrient infusion in chronic hemodialysis patients. We would also like to evaluate the metabolic effects of nutritional supplementation alone without the additional anabolic strategies.
Interventions
- BEHAVIORAL exercise
- DIETARY_SUPPLEMENT nutritional supplement
- DRUG recombinant human growth hormone (rcGH)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 1998-07 |
| Est. Completion | 2006-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00244075
The ClinicalTrials.gov registry entry for NCT00244075 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which exercise is the first listed.
NCT00244075 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00244075 about?
NCT00244075 is a clinical study titled "Effects of Nutritional Supplementation on Protein and Energy Homeostasis in Malnourished Chronic Hemodialysis Patients". The goal of this study is to evaluate the metabolic effects of concomitant use of three consecutive doses of recombinant human growth hormone over three days and exercise during continuous nutrient infusion in chronic hemodialysis patients. We would also like to evaluate the metabolic effects of nut...
What is the current status of trial NCT00244075?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 46 participants. The study started on 1998-07. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00244075?
The interventions under investigation include: exercise (BEHAVIORAL), nutritional supplement (DIETARY_SUPPLEMENT), recombinant human growth hormone (rcGH) (DRUG).
Who is sponsoring clinical trial NCT00244075?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.